What is UltraVoice?
UltraVoice is at the forefront of developing sophisticated voice box devices tailored for individuals who have undergone laryngectomy. Their primary innovation, the UltraVoice device, employs advanced technology to replicate natural voice tones and inflections, thereby substantially improving the communication capabilities and overall quality of life for its users. Distinct from traditional artificial larynxes, the UltraVoice system offers an intuitive user experience, requires no surgical intervention, and dynamically adjusts pitch in real-time, empowering laryngectomees with greater confidence and more natural vocal expression.
How much funding has UltraVoice raised?
UltraVoice has raised a total of $74K across 1 funding round:
Debt
$74K
Debt (2021): $74K with participation from PPP
Key Investors in UltraVoice
PPP
Public-Private Partnership
What's next for UltraVoice?
With the recent influx of substantial expansion capital, UltraVoice is strategically positioned for significant growth. This funding is expected to accelerate product development, enhance manufacturing capabilities, and broaden market reach. The company's focus on improving the quality of life for laryngectomees through innovative voice simulation technology suggests a trajectory towards becoming a leader in assistive communication devices. Future developments may include further integration of AI for even more nuanced voice replication and expanded applications for individuals with other speech-related challenges.
See full UltraVoice company page
